Clinical Trial Results:
A randomized, double-blind, placebo-controlled, parallel group, multicenter two
week study to evaluate the efficacy and safety of once-daily, intranasal
administration of GW685698X aqueous nasal spray 100 mcg in adult and
adolescent subjects with seasonal allergic rhinitis in Europe
Summary
|
|
EudraCT number |
2004-004434-14 |
Trial protocol |
SE LT EE LV |
Global completion date |
12 Aug 2005
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
16 Feb 2016
|
First version publication date |
23 Nov 2014
|
Other versions |
|
Summary report(s) |
FFR103184-Clinical-Study-Result-Summary |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.